DGX Articles, Quest Diagnostics Incorporated

Haystack Oncology, a Quest Diagnostics Inc. (NYSE:DGX) company, announced a research collaboration with Lisata Therapeutics Inc. (NASDAQ:LSTA). Hay...

Quest Diagnostics (NYSE: DGX) recently announced a definitive agreement to purchase the select assets of OhioHealth's outreach laboratory servi...

Quest Diagnostics (NYSE: DGX) has entered into a definitive agreement with OMERS to acquire LifeLabs, a prominent Canadian provider of community la...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...

Cheating on drug tests among American workers has surged to its highest level in over 30 years, according to a lab report from Quest Diagnosti...

Corporate earnings came to the market’s rescue in the past week, helping to overcome rate fears. As we look ahead to the unfolding week, it r...

Tuesday, Quest Diagnostics Inc (NYSE:DGX) posted first-quarter adjusted EPS of $2.04, beating the consensus of $1.86. Sales cam...

Wall Street appears to be shrugging off rate worries as major stock index futures were moderately higher in early pre-market trading on Monday in t...

As the market runs into rough weather, the importance of the upcoming week’s earnings cannot be emphasized enough. A lot is riding on the ear...

Bond appetites are growing as more and more investors look to lock in high-yielding assets ahead of an expected decline in interest rates this year...